Verseon To Present Clinical Data On Anticoagulation Candidates
20 March 2017 - 9:41PM
Alliance News
News) - Verseon
Corp said it will present preclinical data on its low-bleeding-risk
anticoagulation candidates at the ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Verseon (LSE:VSN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Verseon (LSE:VSN)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Verseon (DI) (London Stock Exchange): 0 recent articles
More News Articles